Jimmie L Moore

This inventor holds 20 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Abbott Laboratories Corporation, Chemocentryx, Inc., Medarex Inc.. Active years: 1988-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jimmie L Moore. Retrieved from https://idiyas.com/inventor/jimmie-l-moore

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 20 (Patent Applications = 2)

% Patents Active = 95.0

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 5.6

ph-index = 9

Forward Citations = 453(Granted Patents)

Location History:

Gurnee, IL (US) (1988 - 2003)
Redwood City, CA (US) (2003 - 2022)

Company Filing History:

10 out of 4,190

Abbott Laboratories Corporation

Ligand Pharmaceuticals, Inc.

patents

5. 1 out of 834,601

Other

patents

where one patent can have more than one assignee

Years Active: 1988-2022

Loading Chart...

Areas of Expertise:

Heteroaryl Sulfonamides

Peptidyl Prodrugs

Lipoxygenase Inhibitors

Glucocorticoid Agents

Dihydropyridine Compounds

Iminoxy Derivatives

Arylamidoalkyl Compounds

Cycloalkyl Derivatives

Ether-Containing Inhibitors

Anti-Inflammatory Agents

Potassium Channel Openers

Dibenzofuran Compounds

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11433061 - Heteroaryl sulfonamides and CCR2/CCR9 (2022-09-06),

2. 10532044 - Heteroaryl sulfonamides and CCR2/CCR9 (2020-01-14),

3. 10206912 - Heteroaryl sulfonamides and CCR2/CCR9 (2019-02-19),

4. 8093247 - Heteroaryl sulfonamides and CCR2 (2012-01-10),

5. 7977465 - Peptidyl prodrugs and linkers and stabilizers useful therefor (2011-07-12),

6. RE41252 - Peptidyl prodrugs and linkers and stabilizers useful therefor (2010-04-19),

7. 7622583 - Heteroaryl sulfonamides and CCR2 (2009-11-24),

8. 7507420 - Peptidyl prodrugs and linkers and stabilizers useful therefor (2009-03-24),

9. 7087600 - Peptidyl prodrugs and linkers and stabilizers useful therefor (2006-08-08),

10. 6951942 - Glucocorticoid-selective anti-inflammatory agents (2005-10-04),

11. 6518279 - Cyclopentanone dihydropyridine compounds useful as potassium channel openers (2003-02-11),

12. 6506766 - Glucocortiocoid-selective antinflammatory agents (2003-01-14),

13. 5756531 - Iminoxy derivatives of indole and indene compounds as inhibitors of (1998-05-26),

14. 5514702 - Arylamidoalkyl-N-hydroxyurea compounds having lipoxygenase inhibitory (1996-05-07),

15. 5350765 - Ether-containing inhibitors of 5-lipoxygenase (1994-09-27),

Title: Jimmie L Moore - Pioneering Inventor from Gurnee, IL

Introduction: Jimmie L Moore is a distinguished inventor hailing from Gurnee, Illinois, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Jimmie L Moore's latest patents include cutting-edge inventions in the realm of renewable energy, sustainable technologies, and advanced materials.

Career Highlights: With a career spanning over two decades, Jimmie L Moore has established himself as a visionary inventor with a keen focus on developing solutions that address pressing global challenges. His innovative approach has led to the creation of several patented technologies that have revolutionized industries.

Collaborations: Throughout his career, Jimmie L Moore has collaborated with leading research institutions, universities, and companies to bring his inventions to life. His partnerships have been instrumental in driving forward his vision of a more sustainable and technologically advanced future.

Conclusion: Jimmie L Moore's passion for innovation, coupled with his relentless drive to push the boundaries of what is possible, has cemented his legacy as a trailblazing inventor in the world of technology. His contributions continue to inspire future generations of inventors and shape the landscape of innovation.

Profile summary based on public USPTO records.